Purple Biotech
Open
$1.68
Prev. Close
$1.68
High
$1.68
Low
$1.68
Market Snapshot
$3.05M
0.1
-8022.00
10
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Recently from Cashu
Unable to summarize without specific details on Purple Biotech or related developments.
I can't provide specific content on Purple Biotech or any recent developments without a detailed excerpt from a relevant article. However, if you want a general overview related to stock market gainer…
Request for Content to Summarize on Purple Biotech
It seems that there is no specific content provided for me to summarize regarding Purple Biotech. If you share the text or details you would like summarized, I can create the article as per your reque…
Purple Biotech Reports Promising Clinical Trial Results for Innovative Cancer Therapies
Purple Biotech Advances Cancer Treatment with Promising Clinical Trial Results Purple Biotech, a company specializing in innovative cancer therapies, announces significant progress in its clinical tri…